GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Novanta NOVT · USD

Information Technology · US listing · 🇺🇸 United States

Compare

101.99

-11.22%

Close of 20 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Novanta — daily NOVT Delayed
Market value
$3.74bn
Last close × shares
Volume
852k
Shares, 20 Nov 2026
Price to earnings
99.0

About Novanta

From its filings with the US Securities and Exchange Commission

SEC filings

Novanta is based in Bedford, Massachusetts and is incorporated in New Brunswick, Canada. Its shares trade on Nasdaq under the ticker NOVT. The SEC classifies its business as miscellaneous electrical machinery, equipment & supplies. In the fiscal year to 31 December 2025, it reported revenue of $980.6m and net income of $53.8m. At that date it held total assets of $1.81bn and shareholders' equity of $1.31bn. By business, Robotics and Automation brought in 32.5% of revenue, followed by Advanced Surgery at 24.7% and Precision Medicine at 24.2%. By region, UNITED STATES accounted for 52.9%, followed by Rest Of Europe at 14.0% and GERMANY at 11.7%.

In its own words

Novanta Inc. and its subsidiaries (collectively referred to as the “Company”, “Novanta”, “we”, “us”, “our”) is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers (“OEMs”) a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to solve complex technical challenges. This enables us to engineer proprietary technology solutions that deliver extreme precision and performance, tailored to our customers' demanding applications.

The Company was founded and initially incorporated in Massachusetts in 1968 as General Scanning, Inc. (“General Scanning”). In 1999, General Scanning merged with Lumonics Inc. The post-merger entity, GSI Lumonics Inc., continued under the laws of the Province of New Brunswick, Canada. In 2005, the Company changed its name to GSI Group Inc. Through a series of strategic divestitures and acquisitions, the Company transformed from one that was more focused on the semiconductor industry to one that primarily develops and supplies components and sub-systems to OEMs in the medical and advanced industrial markets. The Company changed its name to Novanta Inc. in May 2016.

Quoted from its 10-K, filed 23 Feb 2026. Read the filing on SEC.gov ↗

More about Novanta →

How it makes its money

Revenue, year to 31 Dec 2025

  • Robotics and Automation $318.6m · 32.5%
  • Advanced Surgery $242.4m · 24.7%
  • Precision Medicine $237.3m · 24.2%
  • Precision Manufacturing [Member] $182.3m · 18.6%

Latest on Novanta

Our reporting

Next results

22 Feb 2027

Due on 22 Feb 2027. Analysts expect earnings of 0.92 a share.

Other Information Technology listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Novanta's ticker?

Novanta trades as NOVT on its US listing, under ISIN CA67000B1040.

What was Novanta's last closing price?

101.99 on 20 Nov 2026. The figure is in USD and is never converted.

When does Novanta next report results?

Results are expected on 9 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.